CLINICAL TRIALS PROFILE FOR TEMOVATE
✉ Email this page to a colleague
All Clinical Trials for TEMOVATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00297011 ↗ | Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis | Completed | GlaxoSmithKline | Phase 2 | 2004-09-01 | A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol gel) versus placebo for the treatment of recurrent herpes labialis (cold sores). |
| NCT00297011 ↗ | Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis | Completed | University of Utah | Phase 2 | 2004-09-01 | A randomized study comparing the combination of valacyclovir and temovate gel (clobetasol gel) versus placebo for the treatment of recurrent herpes labialis (cold sores). |
| NCT00470392 ↗ | Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis | Terminated | University Hospitals Cleveland Medical Center | N/A | 2007-05-01 | The purpose of this study is 1) to determine whether Imiquimod or Steroid pretreatment modifies UVB laser light response resulting in increased cell death compared to UVB laser light alone; 2) to determine if pretreatment of psoriatic lesions with Imiquimod or Steroid prior to UVB laser light exposure selectively effects various T cell functions; 3) to determine clinical results from the Imiquimod/Steroid/UVB laser light and correlate those changes with immuno-histochemical changes in the skin; and 4) to determine if single high dose lesion limited UVB laser light intervention combined with Imiquimod or Steroid influences T cell changes |
| NCT00470392 ↗ | Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis | Terminated | VA Office of Research and Development | N/A | 2007-05-01 | The purpose of this study is 1) to determine whether Imiquimod or Steroid pretreatment modifies UVB laser light response resulting in increased cell death compared to UVB laser light alone; 2) to determine if pretreatment of psoriatic lesions with Imiquimod or Steroid prior to UVB laser light exposure selectively effects various T cell functions; 3) to determine clinical results from the Imiquimod/Steroid/UVB laser light and correlate those changes with immuno-histochemical changes in the skin; and 4) to determine if single high dose lesion limited UVB laser light intervention combined with Imiquimod or Steroid influences T cell changes |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TEMOVATE
Condition Name
Clinical Trial Locations for TEMOVATE
Trials by Country
Clinical Trial Progress for TEMOVATE
Clinical Trial Phase
Clinical Trial Sponsors for TEMOVATE
Sponsor Name
